Načítá se...
Incident adverse events following therapy for acute promyelocytic leukemia
The use of all-trans retinoic acid (ATRA) combined with arsenic trioxide (ATO) with or without cytotoxic chemotherapy is highly effective in acute promyelocytic leukemia (APL) but incident chronic adverse events (AEs) after initiation of therapy are not well understood. We retrospectively analyzed a...
Uloženo v:
| Vydáno v: | Leuk Res Rep |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5993355/ https://ncbi.nlm.nih.gov/pubmed/29892554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2018.05.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|